Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine as adjunctive treatment of schizophrenia
IRCT201710241556N100Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vortioxetine in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Nov 2017; status: completed.
02
Drugs
vortioxetine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201710241556N100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201710241556N100.